Cannabis use in Patients With Inflammatory Bowel Disease is Associated With Longer Endoscopic Duration and Endoscopic Inflammation
IBD cannabis users had longer endoscopic durations and were more likely to exhibit inflammation on endoscopic evaluation compared to cannabis non-users. Our study underscores the importance of medication reconciliation for more accurate resource allocation. Additionally, federal expansion of cannabis research is needed for randomized control trials to fulfill the presently unmet need for data on patient outcomes.
Authors
- Ryan Chadha (ORCID: https://orcid.org/0000-0002-7463-6912)
- Johanna Chan
- Alexander Hochwald (ORCID: https://orcid.org/0009-0009-3651-746X)
- Francis A. Farraye (ORCID: https://orcid.org/0000-0001-6371-2441)
- Lauren Loeb (ORCID: https://orcid.org/0009-0001-9999-6113)
- Jami Kinnucan (ORCID: https://orcid.org/0000-0001-8491-2450)
- Jana G. Hashash (ORCID: https://orcid.org/0000-0001-8305-9742)
- Michael F. Picco
Institutions
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1093/crocol/otaf034
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00